Pacira BioSciences, Inc. — Director's Dealing 2021

Nov 24, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2021-11-22

Reporting Person: LARANJEIRA CHARLES ANTHONY (Chief Technical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-22	Common Stock	M	7500	$44.10	Acquired	33602	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-22	Stock Option (Right to Buy)	$44.10	M	7500	Disposed	2027-06-02	Common Stock (7500)	Direct

Footnotes

F1: Includes 421 shares of common stock acquired under the issuer's employee stock purchase plan in June 2021.

F2: The stock option vested and became exercisable as to 25% of the option shares on May 1, 2018, and vested as to the remaining shares in successive equal quarterly installments over the subsequent three years, provided that the reporting person remained in continuous service with the issuer as of each vesting date.